The week may have ended with all eyes on Canberra, but it began with a pharmacy focus in Brisbane
At the start of the week, the Queensland Parliamentary Inquiry into the pharmacy sector held a public hearing, at which a number of stakeholders, including PSA‘s Shane Jackson and Jacqueline Meyer, QUT‘s Lisa Nissen and TerryWhite Chemmart‘s Anthony White.
Also speaking were Professor Stephen King, who led the recent review into pharmacy regulation and remuneration; and Chemist Warehouse‘s Damien Gance, both of whom had a lot to say on the subject of deregulating the ownership rules. Mr Gance’s comments in particular sparked a rebuttal by Queensland pharmacist and Guild state branch committee member Paul Jaffar.
Meanwhile, the PSA has been behind the scenes working towards incentives for pharmacists to move to the Northern Territory; we looked towards the US, where pharmacists are earning up to AUD$174,000; and we also looked at abuse of analgesics, including pregabalin and opioids in general, while NSW Labor has committed to real time monitoring should it be elected.
We learned that diclofenac up to 2% is set to go general sale; that EBOS had delivered a record profit; and we took another look at how ACT legislators are hoping to reduce certain awkward conversations in pharmacy.
A number of congratulations are in order… to the students who have made the finals of the Guild‘s business plan competition; to Alice Vanderpol and Rebecca Porter, who will be representing their state or territory in the Pharmacy Assistant of the Year Awards; and to Dr Jacinta Johnson, who has joined the SHPA Board.
And of course, it’s been a big week in federal politics, with Scott Morrison now elected as Prime Minister. We don’t know yet what’s next for former Health Minister Greg Hunt, who formally tendered his resignation from the Ministry on Thursday; but we’re looking forward to finding out who the next Health Minister will be. Let us know who you’d like in the job here in our poll!